2009
DOI: 10.1016/j.jss.2007.12.771
|View full text |Cite
|
Sign up to set email alerts
|

The Significance of Arginase I Administration on the Survival of Mice Bearing NS-1 Myeloma Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
2
0
2

Year Published

2009
2009
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 16 publications
1
2
0
2
Order By: Relevance
“…Murine splenic NK cell cytotoxicity in a myeloma tumor model is also impaired by i.v. arginase injection, correlating with a shorter survival of the mice (42). Based on the data in our present study, we hypothesize that arginase within the tumor microenvironment, either myeloid cell-associated (28), passively liberated during PMN cell death (12), or by active secretion (43), suppresses the human antitumor NK cell response by inhibition of NK cell IFN-␥ secretion and proliferation.…”
Section: Discussionsupporting
confidence: 68%
See 1 more Smart Citation
“…Murine splenic NK cell cytotoxicity in a myeloma tumor model is also impaired by i.v. arginase injection, correlating with a shorter survival of the mice (42). Based on the data in our present study, we hypothesize that arginase within the tumor microenvironment, either myeloid cell-associated (28), passively liberated during PMN cell death (12), or by active secretion (43), suppresses the human antitumor NK cell response by inhibition of NK cell IFN-␥ secretion and proliferation.…”
Section: Discussionsupporting
confidence: 68%
“…4B) is in contrast to earlier studies that showed partial inhibition of NK cell-mediated killing upon arginine depletion (42,44). Similarly, cytotoxicity of naive or PHA-activated splenocytes was inhibited in arginase-preincubated medium (45).…”
Section: Discussionmentioning
confidence: 65%
“…A study in syngeneic MM model indicated that ARG1 might play a role in suppressing antitumor immune response—intraperitoneal (i.p.) administration of recombinant ARG1 into mice with NS-1 MM significantly shortened the survival of tumor-bearing animals and impaired NK cells activity 17 . Moreover, bortezomib treatment was associated with increased serum ARG1 levels in MM patients and was suggested to contribute to treatment resistance 18 .…”
Section: Introductionmentioning
confidence: 94%
“…Recientemente Gannon y colaboradores (2010) reportaron que el uso de andrógenos induce la expresión de ARG1 y ARG2 en líneas celulares derivadas de cáncer de próstata. También se ha demostrado que la terapia antiandrogénica reduce la expresión in vitro de ARG2 en el tumor primario de pacientes con este tipo de neoplasia (46). Se ha encontrado la arginasa modulando la función del linfocito T por agotamiento del sustrato; en un modelo murino de trasplante de aloinjerto corneal, la inhibición de la arginasa in vivo aceleró el rechazo y en pequeñas dosis permitió la supervivencia de la piel en el trasplantado; es así como en la inmunología del trasplante de córnea la arginasa tiene un papel en la prevención del rechazo y posiblemente este efecto podría observarse en otros aloinjertos (44).…”
Section: Perspectivas Clínicas Y Aplicacionesunclassified
“…Las concentraciones de arginina, ARG y ONS en la sangre periférica o los tejidos tumorales han mostrado tener relevancia clínica en cuanto a la progresión tumoral, el pronóstico y la supervivencia de pacientes con cáncer (46). Se proponen estos indicadores como una estrategia de seguimiento terapéutico (27).…”
Section: Perspectivas Clínicas Y Aplicacionesunclassified